Glutamic Acid

Glutamic Acid

SCHEMBL174564

CC1CNCCc2ccccc21.N[C@@H](CCC(=O)O)C(=O)O

nearest known ligand 0.59

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR2C P28335 15/20 0.59
HTR2A P28223 12/20 0.59
HTR2B P41595 10/20 0.59
GRM8 O00222 1/20 0.41
GRM6 O15303 1/20 0.41
GRIN2D O15399 1/20 0.41
GRIN3B O60391 1/20 0.41
GSR P00390 1/20 0.41
CYP1A2 P05177 1/20 0.41
GRIK1 P39086 1/20 0.41
GRM5 P41594 1/20 0.41
GRIA1 P42261 1/20 0.41
GRIA2 P42262 1/20 0.41
GRIA3 P42263 1/20 0.41
SLC1A3 P43003 1/20 0.41
SLC1A2 P43004 1/20 0.41
SLC1A1 P43005 1/20 0.41
GRIA4 P48058 1/20 0.41
GRIN1 Q05586 1/20 0.41
GRIN2A Q12879 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Succinic Acid SCHEMBL170444 0.87 HTR2C (0.74) HTR2CHTR2AHTR2BADRB1HTR1A
Lorcaserin SCHEMBL15389716 0.86 HTR2A (0.62) HTR2CHTR2AHTR2BADRB1HTR1A
Lorcaserin SCHEMBL174027 0.86 HTR2A (0.62) HTR2CHTR2AHTR2BADRB1HTR1A
Lorcaserin SCHEMBL175743 0.86 HTR2A (0.62) HTR2CHTR2AHTR2BADRB1HTR1A
Glutamic Acid SCHEMBL161669 0.84 GRM8 (0.39) HTR2CHTR2AHTR2BGRM8GRM6
Glutamic Acid SCHEMBL158772 0.84 GRM8 (0.39) HTR2CHTR2AHTR2BGRM8GRM6
Adipic Acid SCHEMBL173678 0.84 HTR2C (0.70) HTR2CHTR2AHTR2BADRB1HTR1A
Glycolic Acid SCHEMBL173573 0.81 HTR2C (0.74) HTR2CHTR2AHTR2BADRB1HTR1A
Malonic Acid SCHEMBL174816 0.81 HTR2C (0.74) HTR2CHTR2AHTR2BADRB1HTR1A
Alpha-Ketoglutaric Acid SCHEMBL174469 0.81 HTR2C (0.65) HTR2CHTR2AHTR2BADRB1HTR1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2611449-A1 ADMINISTRATION OF LORCASERIN TO INDIVIDUALS WITH RENAL IMPAIRMENT Arena Pharmaceuticals, Inc. (US) 2013-07-10 EP disclosed
WO-2012030939-A1 ADMINISTRATION OF LORCASERIN TO INDIVIDUALS WITH RENAL IMPAIRMENT ARENA PHARMACEUTICALS, INC. (US) 2012-03-08 WO disclosed